Provided by Tiger Trade Technology Pte. Ltd.

Silexion Therapeutics Corp

0.3941
-0.0049-1.23%
Pre-market: 0.3934-0.0007-0.18%07:14 EDT
Volume:226.98K
Turnover:88.47K
Market Cap:2.19M
PE:-0.01
High:0.4056
Open:0.3890
Low:0.3770
Close:0.3990
52wk High:80.00
52wk Low:0.3730
Shares:5.56M
Float Shares:5.48M
Volume Ratio:0.47
T/O Rate:4.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-56.4473
EPS(LYR):-89.5962
ROE:-897.46%
ROA:-123.27%
PB:49.80
PE(LYR):0.00

Loading ...

Nov 19, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2024

Major Issues Report

Form 8-K - Current report
Oct 31, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Oct 15, 2024

Correspondence

Form CORRESP - Correspondence
Oct 09, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Oct 01, 2024

Major Issues Report

Form 8-K - Current report
Sep 24, 2024

Major Issues Report

Form 8-K - Current report
Sep 19, 2024

Major Issues Report

Form 8-K - Current report
Sep 17, 2024

Correspondence

Form CORRESP - Correspondence
Sep 10, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Sep 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 29, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 22, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Aug 22, 2024

Beneficial Ownership Change

Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Aug 22, 2024

Major Issues Report

Form 8-K - Current report
Jul 26, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 26, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jul 16, 2024

Correspondence

Form CORRESP - Correspondence